Page 20«..10..19202122..3040..»

Unite in the Fight: Kickin’ it Challenge Continues Efforts with Breast Cancer Awareness – SoccerNation.com

Posted: June 16, 2017 at 12:46 am

Everyone knows someone who has been affected by breast cancer. In San Diego alone, six women, on average, are diagnosed with breast cancer every single day.

In 2012, when a Poway Youth Soccer player lost her mother to the all too common disease, members of the Poway and surrounding soccer communities rallied together to form a weekend tournament called theKickin it Challenge. The Poway President and current Tournament Organizer Pam Bickel was at the forefront of the movement, withsoccerlocobeing on board as a sponsor since day 1.

Here in the late Spring of 2017, the 6th annualKickin it Challengewill be taking place this weekend, Saturday June 17th and Sunday the 18th, at Ryan Park in Escondido.

Our own Nate Abaurrea caught up with Bickel this week, as the tournament approaches and emotions are already running high. In the conversation, we learn more about the inspirational roots of the tournament, its significance in the local community, and the hopes of its message spreading far beyond the borders of San Diego County.

Nate Abaurrea (SoccerNation): Pam, thanks so much for joining us. I know this is quite the busy time for you. First off, just tell us what this tournament means to you, and why its so important for people in our community to know all about it?

Pam Bickel (Kickin it Challenge): Thanks for having me. Its quite the busy time indeed.

This tournament exists to support breast cancer victims and those affected by breast cancer. Its an alarming stat that 1 in 8 women will likely be diagnosed with some form of breast cancer in their lives.

We started in 2012 when the Poway Soccer Club lost a mom to breast cancer, and the tournament has been something we do every year ever since.

There is a girl currently playing for San Marcos United who lost her mother this year, and she is a big focus of what were doing this time around.

All the money that we raise goes to breast cancer research, but its also so much about just raising awareness. Every year at the tournament we do a challenge called Power of Pink where teams deck themselves out in all pink. We see everything from pink tutus and southern hats to elaborate pink pirate costumes. It creates a good energy, and is all part of the awareness aspect for which we are striving.

Nate Abaurrea (SoccerNation): Im curious to hear you expand on the awareness aspect, especially with young kids who may be learning about this very serious issue for the first time.

Pam Bickel (Kickin it Challenge): Its so important to us. We need to be giving kids that awareness and also be showing ample support to kids who have had to learn about breast cancer so quickly, as they may be going through the pain and angst of having a mother or family member diagnosed. This tournament gives these kids opportunities to become involved with the fight against breast cancer.

Peoples names are written on jerseys and on kids arms. Some kids do temporary tattoos. We have a dedication wall, where people can write messages and sign their own names. This is about celebrating the life of someone who was lost while simultaneously helping to give courage to someone in the midst of their battle with the disease.

Our kids play soccer every weekend, and most days during the week as well. On this coming weekend, they get to play for a bigger cause. The kids themselves get to give back to the community. We all get to Unite in the Fight.

Nate Abaurrea (SoccerNation): What has stood out for you in regards to the support youve received since this tournament started?

Pam Bickel (Kickin it Challenge): The support has been incredible from so many different sources.

I remember when we first started it, some people commented that this would likely only be a girls tournament, because it was in line with breast cancer research and young girls becoming young women. But that simply hasnt been the case at all. The boys teams are all about it, just as much as anybody.

So many of these women who have passed away as a result of breast cancer are mothers to young boys. Those young boys have been greatly affected by this disease, and they need support. This is not just a womens issue. There have been millions of men who have been impacted, and there will sadly be many more. Is it to the same level that the women themselves are affected? No. Its different. But my god, anyone who thinks this is just a womens issue is simply wrong.

I also remember back when we were first conceptualizing this whole thing, and I spoke to John Lococo atsoccerloco. I basically called John and said please tell us why this is crazy and why we shouldnt do this. John said its not crazy at all, and proceeded to give us a sponsorship. John andsoccerlocohave sponsored us from day one, and were now six years running. Weve raised almost $200,000 in that time, and we are excited to break that 200k mark this year.

Another unique concept with the tournament is that its partnered with a silent auction. And one of the more unique brands of support weve received is from all these other soccer clubs from around San Diego, many of whom donate entrances into their tournament to be utilized in the auction. This just keeps a state of connectivity in our soccer community, and makes sure that every club can be a part of this event.

We play the tournament at Ryan Park, which is a fabulous venue. But space is not exactly infinite, and we have to focus on staying within our means. We do everything we can to make this thing enjoyable and memorable. We have pink lines on the field, pink corner flags We have awesome pins that are donated. We have 1stand 2ndplace trophies and medals. We want everybody to truly be involved.

This tournament just has a special feeling. The kids are playing for a bigger cause. Its still good soccer. People still want to win and beat their opposition like any other day. But people have overwhelmingly just said that this tournament is cool. Its unique. Everyone involved has fun.

Nate Abaurrea (SoccerNation): Another word that goes with awareness is education. Talk about the educational powers of an event like this, particularly with young girls and boys.

Pam Bickel (Kickin it Challenge): This is so true. Education is vital, and we have a great opportunity to educate our young people, especially our young women, on some details of breast cancer, what to look for, what to be aware of, and what to do.

The simple awareness aspect is so much about letting everyone know that there might be a woman who has been diagnosed with breast cancer who totally has enough money to pay for her treatment, but she might just need a hug.Breast cancer isnt contagious. Go give that woman a hug!

Again, the awareness is just as important as the fundraising. It all plays a role.

Nate Abaurrea (SoccerNation): Without losing sight of the immediacy of this weekend, where do you hope to see this event go in the coming years?

Pam Bickel (Kickin it Challenge): This tournament has become a support base for people affected by breast cancer in our community. But we also have a great partnership with a club in North Carolina. I was in an airport in North Carolina not too long ago. Some man Id never seen or talked to before was looking at me. He then walked up and commented on myKickin it Challengeshirt and just said thank you. That moment stuck with me. Its about the support and being there for people, helping people truly feel that support.

What we want is for someone to read this article or hear about what we are doing and then do something similar where they live. The dream is for this model to expand well outside of San Diego. It doesnt matter where you are in this world. Everyone knows someone who has been affected by breast cancer. We can all help one another.

Nate Abaurrea (SoccerNation): Pam, thank you so much for discussing this beautiful event with us. Cheers to you and cheers to everyone involved with theKickin it Challenge.

Pam Bickel (Kickin it Challenge): Thanks Nate, and a huge thanks tosoccerlocoand SoccerNation!

(Online donations to the tournament can be made by going to KickinItChallenge.com, and hitting the donate button. soccerloco and SoccerNation is proud to sponsor the 6th annual Kickin it Challenge, taking place this Saturday and Sunday, 6/17 & 6/18, at Ryan Park in Escondido.)

More here:
Unite in the Fight: Kickin’ it Challenge Continues Efforts with Breast Cancer Awareness – SoccerNation.com

Posted in Breast Cancer | Comments Off on Unite in the Fight: Kickin’ it Challenge Continues Efforts with Breast Cancer Awareness – SoccerNation.com

Teen cancer survivor with partial amputation ‘unstoppable’ as athlete – Atlanta Journal Constitution

Posted: at 12:45 am

A cancer diagnosis can be crushing for a person of any age, but Matthew McMahon, an avid athlete, learned he had the disease when he was only 11 years old.

In the moments after the doctor delivered the news, McMahon remembers almost blacking out. He felt weak all over and started seeing spots as his mind tried to make sense of this new, jarring reality.

But, regaining control, the boy vowed to not let a thing like this slow him down. In the months and years following his diagnosis and partial amputation of one of his legs he would resume playing basketball and soccer. And hed even pick up a new sport or two along the way.

Matthew McMahon proudly poses next to his triathlon bike in front of his Woodstock home recently. In 2014, Matthew McMahon was diagnosed with bone cancer. This not only required intensive treatment, but also the amputation of his right leg from the knee down. However, McMahon, who wears a prosthesis, didnt give up being an athlete. CHAD RHYM / CHAD.RHYM@AJC.COM For the AJC

Now 14 years old and a freshman at River Ridge High School in Woodstock, McMahon still loves to play sports. He lives with his family in Woodstock, including his mom, Kerri, his dad, Chris, and his sister, Madison, 10.

A desire to help raise money for childhood cancer research has also led him to get involved with theRally Foundation for Childhood Cancer Research a local organization that empowers volunteers across the country to raise awareness and funds to fight the disease.

On June 25, McMahon will serve as emcee for theseventh annual PT Solutions Allatoona Triathlon, which is a USA Triathlon sanctioned event. Proceeds will benefit the Rally Foundation. And the event is right up his alley.

Being a Rally Kid and having competed in his first post-diagnosis triathlon last August, hes excited about being one of the announcers at this race as well as handing out medals following the event.

One of the biggest adjustments for Matthew McMahon, 14, after his cancer treatment was the conversion to relearn how to ride his bike after the partial amputation of his right leg. CHAD RHYM / CHAD.RHYM@AJC.COM For the AJC

Rally Kids are spokespersons for the Rally Foundation for Childhood Cancer Research. According to the organizations website, they inspire us to keep working hard toward better treatments and cures.

A spokesperson for PT Solutions the physical therapy company hosting the triathlon said the Rally Foundation was a worthy cause.

Working with Rally, we see a lot of cancer patients at our clinic, so we wanted to help and give back to this foundation, said Megan Golden, digital marketing coordinator with PT Solutions.

The race begins at Dallas Landing Park. Racers splash through the lake on a 500-meter swim, emerge from the water for a 16-mile bike race and head back to the park for a 5K run, ending in downtown Acworth.

Golden said McMahon was a natural fit as the events emcee.

Hes a triathlete himself, so he knows what its like to swim and bike and run in a race, Golden said. Hes all around awesome. Matthew is unstoppable, and we just love that. We love his spirit when it comes to competition.

After working on biking and running, Matthew McMahon perfects his freestyle stroke in his neighborhood pool to prepare for a triathlon this August. McMahon takes off his prosthetic leg before engaging in the aquatic sport. On June 25, McMahon, who competed in his first post-cancer diagnosis triathlon last August, will serve as emcee for the seventh annual PT Solutions Allatoona Triathlon. Proceeds will benefit the Rally Foundation for Childhood Cancer Research. CHAD RHYM/ CHAD.RHYM@AJC.COM For the AJC

Competition is whats kept him going throughout diagnosis, partial amputation of his right leg and, now, remission.

I really love sports, and I love competition, McMahon said. I think thats what drove me, was to keep playing sports with my friends and keep up with them and maybe even be better than them.

Matthew McMahon (second from left), who has fought cancer, sits in the family living room in Woodstock with (from left) his mother, Kerri, his sister, Madison, and his father, Chris. He never once said why me? Kerri McMahon said. He just took it head on. Hes had bad days, but his main focus has always been getting back out there with his friends and playing sports again. CHAD RHYM / CHAD.RHYM@AJC.COM For the AJC

Keeping up with his friends meant McMahon had to be cautious, too. The procedure hed undergone in May 2014, which involved partial amputation anda procedure known as rotationplasty, meant he had to pace himself.

Rotationplasty, McMahon explained, is a procedure in which a surgeon removes the knee and takes the bottom of your tibia and fibula in your foot and turns it 180 degrees, and pulls it up and attaches it to your femur, so that your ankle is now your secondary functioning knee.

The other options McMahon had limb salvage (knee replacement) or full amputation wouldnt have allowed him to continue playing contact sports as easily, said his mom, Kerri McMahon.

Kerri said her sons attitude has helped keep her strong throughout all this.

He never once said why me? Kerri McMahon said. He just took it head on. Hes had bad days, but his main focus has always been getting back out there with his friends and playing sports again.

Ways To Keep Cool When the Weather Gets Hot

When asked what kind of advice hed give to someone diagnosed with cancer, Matthew McMahon said its best to focus on the thing that drives you the most. It doesnt matter what that may be, just focus on it, and dont focus on the bad things. Focus on getting better.

Added McMahon: There is a light at the end of the tunnel.

The deadline to register for the seventh annual PT Solutions Allatoona Triathlon is June 18. Those interested can visitactive.com/acworth-ga/triathlon/races/pt-solutions-allatoona-triathlon-2017.

Here is the original post:
Teen cancer survivor with partial amputation ‘unstoppable’ as athlete – Atlanta Journal Constitution

Posted in Cancer Cures | Comments Off on Teen cancer survivor with partial amputation ‘unstoppable’ as athlete – Atlanta Journal Constitution

Texas Oncology Physician Publications | Texas Oncology

Posted: at 12:45 am

2017

Berenson J, Manges R, Badarinath S, Cartmell A, McIntyre K, Lyons R, Harb W, Mohamed H, Nourbakhsh A, Rifkin R.

American Journal of Hematology

A phase 2 safety study of accelerated elotuzumab infusion, over less than 1 hour, in combination with lenalidomide and dexamethasone, in patients with multiple myeloma

2017

Roger M. Lyons, M.D., FACP

Leukemia Research

Relation Between Chelation and Clinical Outcomes in Lower-Risk Patients with Myelodysplastic Syndromes

2016

Mittendorf E.A., Ardavanis A., Symanowski J., Murray J.L., Shumway N.M., Litton J.K., Hale D.F., Perez S.A., Anastasopoulou E.A., Pistamaltzian N.F., Ponniah S., Baxevanis C.N., von Hofe E., Papamichail M., Peoples G.E.

Annals of Oncology

Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence.

2016

Jackson, D and Perez, S and Hale, D and Greene, J and Schneble, E and Martin, J and Flores, M and Berry, J and Trappey, A and Vreeland, TJ, Hardin MO, Clifton GT, Herbert GS, Shumway, N, Papamichail M, Mittendorf EA, Peoples GE

Annals of Surgical Oncology

Correlation Between Preexisting Immunity and Clinical Response in a Phase II Trial Using HER2-Based Peptide Vaccines to Prevent Breast Cancer Recurrence

2016

Vreeland TJ, Jackson DO, Hale DF, Greene JM, Schneble EJ, Martin J, Flores M, Berry JS, Trappey AF, Hardin MO, Clifton GT, Herbert GS, Perez S, Shumway N, Papamichail M, Peoples GE, Mittendorf EA.

Annals of Surgical Oncology

Efficacy of Booster Inoculations in a Phase II Trial of GP2, a HER2-Derived Peptide Vaccine, for the Prevention of Breast Cancer Recurrence

2016

Hardin MO, Jackson DO, Hale DF, Greene JM, Schneble EJ, Martin J, Flores M, Berry JS, Trappey AF, Vreeland TJ, Clifton GT, Herbert GS, von Hofe E, Perez S, Shumway N, Papamichail M, Peoples GE, Mittendorf EA.

Annals of Surgical Oncology

Impact of Boosting in the Phase II Trial of the AE37+ GM-CSF Vaccine in High-risk Breast Cancer Patients to Prevent Recurrence

2016

Giuliani M, Hope A, Mangona VS, Guckenberger M, Mantel F, Peulen H, Sonke J, Belderbos J, Werner-Wasik M, Ye H, Grills IS.

Clinical Lung Cancer

Predictors and Patterns of Regional Recurrence Following Lung SBRT: A Report From the Elekta Lung Research Group.

2016

Johnson MD, Sura K, Mangona VS, Glick A, Ye H, Grills IS

Clinical Lung Cancer

Matched Pair Analysis of High Dose versus Standard Dose Definitive Chemoradiation for Locally Advanced Non-small Cell Lung Cancer.

2016

Wilks, Sharon T. &Schnadig, Ian

Future Oncology

APF530 (Granisetron Inj Extended-Release) in a Three-Drug Regimen for Delayed CINV in Highly Emetogenic Chemotherapy

2016

Agiro A, Ma Q, Acheson AK, Wu SJ, Patt DA, Baron JJ, Malin J, Schilsky RL, Lyman GH

Journal of Clinical Oncology

Risk of Neutropenia-Related Hospitalization in Patients Who Received Colony-Stimulating Factors with Chemotherapy for Breast Cancer

2016

Hirsch BR, Burke JM, Agrawal M, Hauke RJ, Hutson TE, Doshi G, et al.

Journal of Kidney Cancer and VHL

Sequential therapy in metastatic renal cell carcinoma.

2016

Patt D

Journal of Oncology Practice

Better Screening Using Big Data

2016

Chiu L., Chow R., Popovic M., Navari R.M., Shumway N.M., Chiu N., Lam H., Milakovic M., Pasetka M., Vuong S., Chow E.,DeAngelis C.

Support Care Cancer

Efficacy of olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis.

2015

Isis Gayed, MD, Robert Amato,MD, Gurjyot Doshi, MD, Mina Fanous,MD, David Wan,MD, Usha Joseph, MD, Steven Canfield, MD.

2015 World Molecular Imaging Congress. Hawaii

Early experience with Radium 223 Xofigo Therapy in Patients with Prostate Bony Metastases Poster Presentation

2015

Zhu XR, Li Y, Mackin D, Li H, Poenisch F, Lee AK, Mahajan A, Frank SJ, Gillin MT, Sahoo N, Zhang X

Cancers

Towards effective and efficient patient-specific quality assurance for spot-scanning proton therapy

2015

Mangona VS, Aneese AM, Hymas RV, Marina 0, lonascu D, Gallardo LJ, Yan D, Robertson JM, Grills IS

International Journal of Radiation Oncology, Biology and Physics

Toxicity After Central versus Peripheral Stereotactic Lung Radiotherapy (SBRT): A Propensity Score Matched-Pair Analysis.

2015

V.S. Mangona, D.R. Grosshans, M. Chintagumpala, S. Khatua, N.V. Philip, M.F. McAleer, S.L. McGovern, J. Su, M.F. Okcu, A.C. Paulino, A. Mahajan

International Journal of Radiation Oncology, Biology and Physics

A. Clinical Outcomes of Children with Medulloblastoma After Proton Radiotherapy.

2015

Schadendorf D, Hodi FS, Robert C, Weber JS, Margolin K, Hamid O, Patt D, Chen TT, Berman DM, Wolchok JD

Journal of Clinical Oncology

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

2015

John F. Sandbach Gayle Patel, Elizabeth King, Brent Evans, John Kidd, Lucy Langer, Krystal L. Brown, Richard Wenstrup, Jennifer Saam

2015 ASCO Annual Meeting

A Study of Triple-Negative Breast Cancer Patients Tested With a 25-Gene Panel of Hereditary Cancer Genes.

2015

Wilks, Sharon T., Yardley, etal.

American Society of Clinical Oncology

Weekly nab-Paclitaxel plus Gemcitabine (Gem) or Carboplatin (Carbo) versus Gem/Carbo as First Line Treatment for Metastatic Triple Negative (mTNBC) in a Phase II/III Trial (TnAcity).

2015

Wilks, Sharon T.,Slamon, et al.

American Society of Clinical Oncology

Predictive Biomarkers of Everolimus efficacy in HER2+ Advanced Breast Cancer: Combined Exploratory Analysis from BOLERO-1 and BOLERO-3.

2015

Bersabe, Adrian REYES and Osswald, Michael B and Shumway, Nathan M

ASCO Annual Meeting Proceedings

Correlation of peripheral blood smear review and bone marrow biopsies for benign hematology Outpatient referrals.

2015

Greene JM, Schneble EJ, Martin J, Flores M, Berry, Trappey AF, Vreeland TJ, Hale DF, Sears AK, Clifton GT, von Hofe E, Ardavannis A, Shumway N, Ponniah S, Papamichail M, Perez S, Symanowski JT, Peoples GE, Mittendorf EA.

ASCO Annual Meeting Proceedings

Final pre-specified analysis of the phase II trial of the AE37+ GM-CSF vaccine in high risk breast cancer patients to prevent recurrence.

2015

Liang C, Li L, Fraser CD, Ko A, Corzo D, Enger C, Patt D

BMC Cancer

The treatment patterns, efficacy, and safety of nab-paclitaxel for the treatment of metastatic breast cancer in the United States: results from health insurance claims analysis

2015

Wilks, S. & McIntyre, K

Clinical Medicine Insights: Oncology

Case Studies in the Management of Metastatic Breast Cancer with Eribulin.

Visit link:
Texas Oncology Physician Publications | Texas Oncology

Posted in Oncology | Comments Off on Texas Oncology Physician Publications | Texas Oncology

Personalized Medicine and the Role of the Oncology Navigator – Oncology Nurse Advisor

Posted: at 12:45 am


Oncology Nurse Advisor
Personalized Medicine and the Role of the Oncology Navigator
Oncology Nurse Advisor
Nurse navigators can ensure timely diagnosis and treatment planning as well as educating patients and managing expectations. Read more of Oncology Nurse Advisor's coverage of the 2017 Oncology Nurse Advisor Navigation Summit by visiting the …

See more here:
Personalized Medicine and the Role of the Oncology Navigator – Oncology Nurse Advisor

Posted in Oncology | Comments Off on Personalized Medicine and the Role of the Oncology Navigator – Oncology Nurse Advisor

Pop-up trial sites and the future of personalized oncology care – MedCity News

Posted: at 12:45 am

Gaurav Singal was a successful computer scientist. The language of programming just clicked, he said. But there was a sense of purpose and meaning missing, so he headed off to medical school.

He is now vice president of data strategy and product development at Foundation Medicine, a company that was founded with that scientist-clinician mentality baked in. Thats important, Singal said, because it helps the team think about the practical application of what they do withgenomics, diagnostics, and data.

As everyone knows, these technologies dont exist in a vacuum. The realities of healthcare too often get in the way and limit medical advances to patients at major academic institutions.

Thankfully, theres a technology solution for expanding access too.

In a recent phone interview, Singal discussed how Foundation is overcoming precision healthcare barriers by connecting community cancer centers with tests and clinical trials. Also in the works: A universal companion diagnostic, which could help disrupt the field.

Singal will also be discussing the limitations of precision medicine on August 1, at the MedCity CONVERGE conferencein Philadelphia.

Community cancer care

On May 23, FDA delivered a monumental ruling: It approved Mercks checkpoint inhibitor Keytruda for a range of solid tumors. For the first time, the deciding factor was not what tissue the persons cancer originated in; it was whether the cells expressed so-called mismatch repair genes.

It was a symbolic moment for precision medicine, but it also raised some questions about the reality of its application. For clinicians to identify the right patients, they need to have their tumors sequenced. This frequently doesnt happen outside of the major academic centers.

Foundation is working hard to ensure its diagnostics make it to community cancer centers as a routine part of oncology care, Singal said. Of the 40,000 tests it ran last year, over half came from community centers.

But what good are the sequencing results if the patient doesnt have access to the relevant drugs, many of which are in clinical trials?

Thats another area that has traditionally be focused on major academic centers, where these clinical trials are run, Singal said.

To combat this, the company has launched Foundation SmartTrials, which helps pharma companies optimize their clinical trials. Part of Foundations job is to cast a wide net, to efficiently capture patients with the target mutations. Its in everyones interests for the patients to be matched with the right precision medicine study, after all.

Basically, it helps enable awareness and access. Especially for patients with rare genomic mutations, but not exclusively, Singal explained. That helps find clinical trial options that may be relevant for them, in concert with their histological and anatomical disease.

One example the company cites is a trial that waslooking for a rare fusion of a protein called ROS1. It occurs in around 1-2 percent of patients with non-small cell lung cancer (NSCLC). During the trial, a patient with this mutation was identified in a non-academic setting.

One of our staff oncologists reached out to that provider to tell them about the availability of this clinical trial and its relevance for that particular finding, Singal said. The provider and patient consulted and decided that they wanted to try that route, but they didnt have access to the trial because it wasnt an academic center.

Tapping into its partnership with a network of just-in-time sites, Foundation was able to get a new site activated to treat this individual. Within seven days of finding the mutation, the patient was screened, enrolled, and getting access to the drug at his local center.

Which is an unheard of rate, especially for a non-academic site, Singal added.So thats the kind of thing I think will be required for this medicine to be democratized.

Universal companion diagnostics

Another potential tool for the disruption of cancer genomics is waiting in the wings. U.S. and European regulatory agencies are currently evaluating a universal companion diagnostic created by Foundation. (Thermo Fisher Scientific has a similar test the Oncomine Universal Dx also undergoing FDA review.)

Singal expects an approval to be a watershed moment for the field. It will bring a new level of rigor and scientific scrutiny, he said, noting that the tests are complicated and that lives are potentially at stake.

Perhaps more importantly, a universal companion diagnostic could totally recast the economic feasibility of genomic tests in cancer.

The traditional model of one test for one drug is really hard to sustain when some of the things were looking for are really rare, Singal explained.

Using the ROS1 example, 98-99 percent of patients would test negative for the mutation. Can payers and providers justify testing that many patients for one or two hits? On the flipside, how many different mutations do you test for in each and every individual? If someone is weakly positive for a druggable mutation, do you keep ordering and paying for tests?

A universal diagnostic could test for dozens of mutations in a single run, vastly increasing the actionability of each test and giving patients the best options and perhaps more options for treatment.

With these kinds of advances, precision medicinecan hopefully become the standard-of-care throughout the United States and beyond.

Photo: Natali_Mis, Getty Images

Continued here:
Pop-up trial sites and the future of personalized oncology care – MedCity News

Posted in Oncology | Comments Off on Pop-up trial sites and the future of personalized oncology care – MedCity News

Veteran Hematologist and Oncologist, John Imperio, MD, is to be Recognized as a 2017 Top Doctor in Staten Island … – PR NewsChannel (press release)

Posted: at 12:44 am

John Imperio, MD, currently serves as the Chief of Hematology and Oncology, and President of the medical and dental staff within Sea View Hospital Rehabilitation Center and Home, has been named a 2017 Top Doctor in Staten Island, New York. Top Doctor Awards is dedicated to selecting and honoring those healthcare practitioners who have demonstrated clinical excellence while delivering the highest standards of patient care.

Dr. John Imperio is a vastly experienced physician, having been in practice for over 45 years. His long and successful career in medicine started in 1966, when he graduated from the University of Padua College of Medicine in Italy. After moving to the United States, he completed an internship at Nassau County Medical Center Long Island, followed by residencies at the Bronx VA hospital and Mount Sinai.He did a fellowship in Hematology and Oncology at St. Vincents Catholic Medical center.

Dr. Imperio is triple board certified in Internal Medicine, Geriatric Medicine, and Hematology. He has become internationally renowned as an expert in these latter two fields. He diagnoses and treats a wide range of conditions, from cancers and leukemia to blood disorders and conditions that typically affect older patients,dementia.including Alzheimers disease.

With his wealth of experience to call upon, Dr. Imperio is a physician , and yet he still takes time to talk to his patients and family members, discussing their conditions and how to manage or treat them. This laudable attitude makes Dr. John Imperio a very worthy winner of a 2017 Top Doctor Award.

About Top Doctor Awards

Top Doctor Awards specializes in recognizing and commemorating the achievements of todays most influential and respected doctors in medicine. Our selection process considers education, research contributions, patient reviews, and other quality measures to identify top doctors.

Here is the original post:
Veteran Hematologist and Oncologist, John Imperio, MD, is to be Recognized as a 2017 Top Doctor in Staten Island … – PR NewsChannel (press release)

Posted in Oncologist | Comments Off on Veteran Hematologist and Oncologist, John Imperio, MD, is to be Recognized as a 2017 Top Doctor in Staten Island … – PR NewsChannel (press release)

Cannabis Mom CEO on cancer treatment research – Fox Business

Posted: at 12:43 am

As the Cannabis World Congress & Business Exposition descends on New York City this week, its a good reminder that success in the cannabis industry is an effective combination of solid strategic partnerships along with spreading the word of the wonderful benefits of cannabis, whether its just through social media or through participating in events. Just like many people, my journey as an entrepreneur in this industry started with a very personal story.

In 2013, my nearly 9-month-old daughter Sophie was diagnosed with a brain tumor, which would require a 13-month treatment of chemo. We were told that this treatment would most likely only stop the current growth and not shrink or stop any of the current issues Sophie was suffering. After getting connected with top cannabis oil makers and experts, we started Sophie on a high-concentrated THC and CBD cannabis oil regimen that started in conjunction with her 13-month chemo treatments. Because of this the only side effects Sophie encountered was a little sleeplessness, which went away while she acclimated to the cannabis regiment, and hunger, which was amazing since chemo is known to affect appetite.

The results astounded us, Sophies tumor not only stopped growing it shrank by 85 percent. On top of that we were told that Sophie would be completely blind or have minimal vision as a best-case scenario, but due to the shrinkage brought on by the cannabis oils, her vision was saved.

Due to this miracle that we encountered, I knew that I had to do something more, something that involved bringing cannabis oils like the ones Sophie took to others who are suffering from similar situations, especially around pediatric cancer. Thus, CannaKids, a California Cooperative Corporation, was born in 2015 and to date has helped nearly 1,000 patients with our scientifically developed cannabis oil products for both children and adults. It also works in tandem with the charitable foundation SavingSophie.org.

Additionally, CannaKids is actively working with other companies, like Cure Pharmaceutical to do further studies on cannabis and how they can help treat various diseases. Recently the two companies joined forces with Technion Research & Development in Israel, where they are going to be researching cannabis and how it can treat various cancers.

The opinions expressed in this column are those of the columnist, and not FOXBusiness.com.

Read more:
Cannabis Mom CEO on cancer treatment research – Fox Business

Posted in Cancer Treatment | Comments Off on Cannabis Mom CEO on cancer treatment research – Fox Business

Cancer’s Big Infrastructure Problem – Forbes

Posted: at 12:43 am


Forbes
Cancer's Big Infrastructure Problem
Forbes
Laura Greco thought it was the car accident she had to worry about. An SUV had swiped her while she was driving her six-year-old home from ski lessons on a snowy day. When doctors offered to scan her body for trauma, she says she agreed not only …

Read the original post:
Cancer’s Big Infrastructure Problem – Forbes

Posted in Cancer | Comments Off on Cancer’s Big Infrastructure Problem – Forbes

Higher Odds for Certain Cancers for Couch Potatoes – WebMD

Posted: at 12:43 am

By Robert Preidt

HealthDay Reporter

THURSDAY, June 15, 2017 (HealthDay News) — Add greater risk of kidney and bladder cancer to the long list of why a lifetime of sitting on the sofa isn’t good for your health, a new study suggests.

Specifically, lifetime recreational inactivity was associated with a 73 percent increased risk of bladder cancer and a 77 percent increased risk of kidney cancer.

The findings add to growing evidence that inactivity may be a significant risk factor for cancer, the researchers said.

“We hope that findings like ours will motivate inactive people to engage in some form of physical activity,” said study senior author Kirsten Moysich. She is a professor of oncology at Roswell Park Cancer Institute in Buffalo, N.Y.

“You don’t have to run marathons to reduce your cancer risk, but you have to do something — even small adjustments like taking the stairs instead of the elevator, walking around the block a couple of times on your lunch hour or parking the car far away from the store when you go to the supermarket,” she said in an institute news release.

The study included 160 kidney cancer patients, 208 bladder cancer patients and 766 people without cancer. Cancer risks were similar whether people were obese or not, the researchers said.

The study was only designed to show an association between a sedentary lifestyle and the risk of these cancers; it cannot prove a cause-and-effect relationship.

“Our findings underscore how important it is to maintain a healthy lifestyle, including getting and staying active,” study first author Rikki Cannioto, an assistant professor of oncology at Roswell Park, said.

“The Department of Health and Human Services recommends 150 minutes each week of moderate physical activity or 75 minutes each week of vigorous physical activity as a way to generate significant, lasting health benefits,” Cannioto said.

The study was published recently in the journal Cancer Epidemiology.

WebMD News from HealthDay

SOURCES: Roswell Park Cancer Institute, news release, May 24, 2017

Here is the original post:
Higher Odds for Certain Cancers for Couch Potatoes – WebMD

Posted in Cancer | Comments Off on Higher Odds for Certain Cancers for Couch Potatoes – WebMD

‘Monumental U-turn’ on cancer drug – BBC News

Posted: at 12:43 am


BBC News
'Monumental U-turn' on cancer drug
BBC News
A pioneering and life-extending drug repeatedly deemed too expensive will now be offered on the NHS in England. It is the result of a confidential deal between the health service and the drug company Roche. Kadcyla, the undiscounted cost of which had …
Breast cancer drug that can extend lives approved for NHS useThe Guardian
New breast cancer drug called 'too expensive' now available on the NHSThe Independent
'Monumental' NHS U-turn on breakthrough breast cancer drug is hailed by patient groupsTelegraph.co.uk
Medscape –The Sun –Reuters
all 24 news articles »

See the original post:
‘Monumental U-turn’ on cancer drug – BBC News

Posted in Cancer | Comments Off on ‘Monumental U-turn’ on cancer drug – BBC News

Page 20«..10..19202122..3040..»